Amantadine and Olanzapine interaction
Amantadine and Olanzapine: both prescribing labels describe an interaction that usually calls for monitoring, a dose change, or spacing the doses.
Usually manageable with monitoring or a dose change. Tell your pharmacist you take both.
What the FDA labels say
From the Amantadine (GOCOVRI) label · effective 2026-02-16
Withdrawal-Emergent Hyperpyrexia and Confusion A symptom complex resembling neuroleptic malignant syndrome (characterized by elevated temperature, muscular rigidity, altered consciousness, and autonomic instability), with no other obvious etiology, has been reported in association with rapid dose reduction, withdrawal of, or changes in drugs that increase central…
Other Anticholinergic Drugs: Doses should be reduced if atropine-like effects occur ( 7.1 )
Other Anticholinergic Drugs Products with anticholinergic properties may potentiate the anticholinergic-like side effects of amantadine.
From the Olanzapine (Zyprexa) label · effective 2026-02-11
Anticholinergic (antimuscarinic) Effects: Use with caution with other anticholinergic drugs and in patients with urinary retention, prostatic hypertrophy, constipation, paralytic ileus or related conditions.
Levodopa and Dopamine Agonists: May antagonize levodopa/dopamine agonists.
Levodopa and Dopamine Agonists — Olanzapine may antagonize the effects of levodopa and dopamine agonists.
Taking more than these two? Interactions stack. Check your whole list at once; it stays in your browser.
Open in the checkerNot medical advice. Interaction Checker quotes FDA label text and NIH fact sheets. Whether an interaction matters for you depends on doses, timing, kidney and liver function, and other conditions. Confirm with a pharmacist or prescriber.